GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (NYSE:WAT) » Definitions » EV-to-EBITDA

Waters (Waters) EV-to-EBITDA

: 20.63 (As of Today)
View and export this data going back to 1995. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Waters's enterprise value is $20,653 Mil. Waters's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,001 Mil. Therefore, Waters's EV-to-EBITDA for today is 20.63.

The historical rank and industry rank for Waters's EV-to-EBITDA or its related term are showing as below:

WAT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.37   Med: 17.63   Max: 28.67
Current: 20.63

During the past 13 years, the highest EV-to-EBITDA of Waters was 28.67. The lowest was 12.37. And the median was 17.63.

WAT's EV-to-EBITDA is ranked worse than
70% of 120 companies
in the Medical Diagnostics & Research industry
Industry Median: 15.06 vs WAT: 20.63

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-18), Waters's stock price is $304.18. Waters's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $10.850. Therefore, Waters's PE Ratio for today is 28.04.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Waters EV-to-EBITDA Historical Data

The historical data trend for Waters's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.30 20.92 24.07 21.07 21.51

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.07 19.40 18.10 18.37 21.51

Competitive Comparison

For the Diagnostics & Research subindustry, Waters's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters EV-to-EBITDA Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Waters's EV-to-EBITDA falls into.



Waters EV-to-EBITDA Calculation

Waters's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=20652.949/1001.009
=20.63

Waters's current Enterprise Value is $20,653 Mil.
Waters's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,001 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters  (NYSE:WAT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Waters's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=304.18/10.850
=28.04

Waters's share price for today is $304.18.
Waters's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.850.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Waters EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Waters's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (Waters) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.
Executives
Christopher A Kuebler director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Richard H Fearon director 1239 GERBING ROAD, AMELIA ISLAND FL 32034
Edward Conard director
Daniel J. Brennan director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Mark P Vergnano director 1007 MARKET STREET, WILMINGTON DE 19898
Gary E Hendrickson director 1101 THIRD STREET SOUTH, MINNEAPOLIS MN 55415
John M Ballbach director
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Michael J Berendt director
Thomas P Salice director
Wei Jiang director 34 MAPLE STREET, MILFORD MA 01757
Amol Chaubal officer: SVP and Chief Financial Office 113 HARTWELL AVE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421
Jianqing Bennett officer: SVP TA Instruments Division 34 MAPLE STREET, MILFORD MA 01757
Joann A Reed director C/O AMERICAN TOWER CORP, 116 HUNTINGTON AVENUE, BOSTON MA 02116
Belinda Hyde officer: SVP, Global Human Resources 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277

Waters (Waters) Headlines

From GuruFocus

Q3 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Waters Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Waters Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024